Portrait of Line Jacques
ucsf logobch logo

Line Jacques, MD, MS

Pediatric Neurosurgery • Neurosurgery
Neurosurgery Parnassus
415-353-7500
Portrait of Line Jacques
Portrait of Line Jacques
ucsf logobch logo

Line Jacques, MD, MS

Pediatric Neurosurgery • Neurosurgery
Neurosurgery Parnassus
415-353-7500

On this page

Education & training

Board certification

  • Neurological Surgery, American Board of Neurological Surgery

Fellowship

  • Neurosurgery, Louisiana State University (LSU) - Shreveport GME

Residency

  • Neurosurgery, University of Montreal Hospital Saint-Luc

Internship

  • General Surgery, St. Luc Hospital

Degree

  • MD, Universite de Montreal

Academic title

  • Clinical Professor

My expertise

  • Specialties
  • Conditions
    • Peripheral Nerve Tumor

Locations

    Reviews

    Average rating

    4.7
    4.7 out of 5 Stars
    420 ratings
    About provider reviews

    Showing 1-6 of 99 reviews

    Sort by
    • 4.9 out of 5 Stars
      August 8, 2026

      Dr. Jacques is very kind and provides thorough care.

    • 5 out of 5 Stars
      August 6, 2026

      Very good

    • 5 out of 5 Stars
      August 5, 2026

      I am grateful for Dr. Jacques' care

    • 5 out of 5 Stars
      August 3, 2026

      Appreciate time Dr. Jacques and Kim Ly took to listen to my concerns and answer my questions.

    • 5 out of 5 Stars
      July 30, 2026

      Dr Jacques is excellent!

    • 5 out of 5 Stars
      July 14, 2026

      Im very happy the way the Doctor explained what they going to do ,Im just waiting for an appoitment

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.